4B-MAR, 4C-MAR, and 4F-MAR characterize a carefully relevant team of novel psychoactive substances (NPS) throughout the 2-amino-5-aryloxazoline family. They can be synthetic stimulants which have emerged as designer medications, made as structural analogs of the father or mother compound 4-methylaminorex (4-MAR) to bypass current drug scheduling li